Bo Chen

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2025
CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.

Danian Dai, Jinhui Zhang, Yunxian Mo

|May 12, 2025
Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma.

Hongkai Zhuang, Chenwei Tang, Wentao Wang

|Nov 04, 2024
Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients.

Danian Dai, Xuerui Li, Hongkai Zhuang

|Aug 31, 2021
CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.

Jianguo Lai, Xiaoyi Lin, Fangrong Cao

|Jul 19, 2021
Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.

Hongkai Zhuang, Xinming Chen, Ying Wang

|Feb 13, 2021
Prognostic values and immune suppression of the S100A family in pancreatic cancer.

Hongkai Zhuang, Xinming Chen, Fengying Dong

Pageof 1